Please wait while the formulary information is being retrieved.
EMTRIVA (EMTRICITABINE)
- HIV infection
10 mg/mL oral solution
- 24 milliliters (240 mg) by oral route once daily
200 mg capsule
- 1 capsule (200 mg) by oral route once daily
HIV infection
- 1 capsule (200 mg) by oral route once daily
- 24 milliliters (240 mg) by oral route once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- Lactating mother
- Lactic acidosis
Contraindicated
- Kidney disease with reduction in GFR
Severe
Moderate
- Chronic hepatitis B
EMTRIVA (EMTRICITABINE)
- HIV infection
- Depression
- Gastroenteritis
- Vomiting
- Acute abdominal pain
- Cough
- Diarrhea
- Dizziness
- Dream disorder
- Fatigue
- General weakness
- Headache disorder
- Nausea
- Pruritus of skin
- Rhinitis
- Skin rash
More Frequent
Severe
Less Severe
- Anemia
- Bullous dermatitis
- Maculopapular rash
- Peripheral neuropathy
- Urticaria
- Acute bacterial otitis media
- Arthralgias
- Dyspepsia
- Insomnia
- Myalgias
- Paresthesia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Graves' disease
- Guillain-barre syndrome
- Lactic acidosis
- Pneumonia
- Polymyositis
- Steatosis of liver
Less Severe
- Dyschromia
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Emtricitabine
- Severity Level:
2
- Additional Notes: Available human data show no increased risk for major malformations.
Contraindicated
Emtricitabine
Cdc does not recommend breastfeeding in hiv-positive women.
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Excreted | Not known; no or inclusive data | Cdc does not recommend breastfeeding in hiv-positive women. |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Emtricitabine
Renal- Adhere to manufacturer guidelines for renal impairment and lower CrCL.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | Y | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- This medication is not approved for the treatment of hepatitis B virus infection. If you have hepatitis B infection in addition to HIV, your hepatitis symptoms may get worse or become very serious if you stop taking emtricitabine. Talk with your doctor before stopping this medication.<br /><br />Your doctor will perform liver function tests for several months after you stop emtricitabine. Tell your doctor right away if you develop symptoms of worsening liver problems.
| HIV infection | |
| B20 | Human immunodeficiency virus [HIv] disease |
| B97.35 | Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere |
| O98.7 | Human immunodeficiency virus [HIv] disease complicating pregnancy, childbirth and the puerperium |
| O98.71 | Human immunodeficiency virus [HIv] disease complicating pregnancy |
| O98.711 | Human immunodeficiency virus [HIv] disease complicating pregnancy, first trimester |
| O98.712 | Human immunodeficiency virus [HIv] disease complicating pregnancy, second trimester |
| O98.713 | Human immunodeficiency virus [HIv] disease complicating pregnancy, third trimester |
| O98.719 | Human immunodeficiency virus [HIv] disease complicating pregnancy, unspecified trimester |
| O98.72 | Human immunodeficiency virus [HIv] disease complicating childbirth |
| O98.73 | Human immunodeficiency virus [HIv] disease complicating the puerperium |
| Z21 | Asymptomatic human immunodeficiency virus [HIv] infection status |
| 0-9 | A-Z |
|---|---|
| B20 | Human immunodeficiency virus [HIv] disease |
| B97.35 | Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere |
| O98.7 | Human immunodeficiency virus [HIv] disease complicating pregnancy, childbirth and the puerperium |
| O98.71 | Human immunodeficiency virus [HIv] disease complicating pregnancy |
| O98.711 | Human immunodeficiency virus [HIv] disease complicating pregnancy, first trimester |
| O98.712 | Human immunodeficiency virus [HIv] disease complicating pregnancy, second trimester |
| O98.713 | Human immunodeficiency virus [HIv] disease complicating pregnancy, third trimester |
| O98.719 | Human immunodeficiency virus [HIv] disease complicating pregnancy, unspecified trimester |
| O98.72 | Human immunodeficiency virus [HIv] disease complicating childbirth |
| O98.73 | Human immunodeficiency virus [HIv] disease complicating the puerperium |
| Z21 | Asymptomatic human immunodeficiency virus [HIv] infection status |
Formulary Reference Tool